Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2010
03/24/2010CN101679421A New imidazo[ 4,5-b]pyridine-7-carboxamides 704
03/24/2010CN101679417A New 4,8-diphenyl-polyazanaphthalene derivatives
03/24/2010CN101679403A Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators 842
03/24/2010CN101679402A Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators 841
03/24/2010CN101679399A Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
03/24/2010CN101679385A Prolinamide-tetrazole derivatives as NK3 receptor antagonists
03/24/2010CN101679381A Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
03/24/2010CN101679379A arylamide pyrimidone compounds
03/24/2010CN101679366A pyridyl piperidine orexin receptor antagonists
03/24/2010CN101679364A heteroarylamide pyrimidone compounds
03/24/2010CN101679351A Quinoline compounds suitable for treating didorders that respond to modulation of the serotonin 5-ht6 receptor
03/24/2010CN101679349A 3-cyano-4-(4-phenyl-piperidin-1-yl)-pyridin-2-one derivatives
03/24/2010CN101679348A 5-pyridinone substituted indazoles
03/24/2010CN101679330A metabolites of (thio)carbamoyl-cyclohexane derivatives
03/24/2010CN101679315A Novel piperazine salts as d3/d2 antagonists
03/24/2010CN101679306A Heteroarylamide pyrimidone derivatives
03/24/2010CN101679305A Arylamide pyrimidone derivatives
03/24/2010CN101679304A Pyridazine-, pyridine- and pyrane-derivatives as GPBAR1 agonisis
03/24/2010CN101679288A Indazoles used to treat estrogen receptor beta mediated disorders
03/24/2010CN101679279A Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
03/24/2010CN101679276A Isoquinolinone derivatives as nk3 antagonists
03/24/2010CN101679273A 1-substituted tetrahydroisoquinoline compound
03/24/2010CN101679271A Quinoline derivatives, pharmaceutical compositions comprising them, and their use in treating central nervous system and peripheral diseases
03/24/2010CN101679263A fluorinated derivatives of deferiprone
03/24/2010CN101679261A Piperazine and piperidine mglur5 potentiators
03/24/2010CN101679249A Indole and benzothiophene compounds as modulators of the histamine h3 receptor
03/24/2010CN101679241A Prolinamide derivatives as NK3 antagonists
03/24/2010CN101678212A Pharmaceutical compositions and method for treating acute mania
03/24/2010CN101678097A Vaccination regimen for b-cell vaccines
03/24/2010CN101678080A Therapeutic effects of bryostatins, bryologs, and other related substances on ischemia/stroke-induced memory impairment and brain injury
03/24/2010CN101678059A New use for cannabinoid-containing plant extracts
03/24/2010CN101678047A Remedy and diagnostic for mitochondrial dysfunction brain disease
03/24/2010CN101678025A Tetrahydrobiopterin compositions, and methods of measuring
03/24/2010CN101678022A 5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
03/24/2010CN101678018A (thio) -carbamoyl-cyclohexane derivatives and method for treating schizophrenia
03/24/2010CN101678010A A composition comprising (r)-spiro[l- azabicyclo[2.2.2]octane-3,2'(3'h) -furo[2,3 -b]pyridine (azd0328) and its use in the treatment of alzheimer's disease, adhd or cognitive dysfunction
03/24/2010CN101678006A Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient
03/24/2010CN101677998A a medicament for treating schizophrenia comprising cilostazol
03/24/2010CN101677988A Composition for transdermal or transmucosal administration
03/24/2010CN101677973A Composition comprising terpene compounds and methods for inhibiting nerve transmission
03/24/2010CN101677972A Novel combinations of neramexane for the treatment of neurodegenerative disorders
03/24/2010CN101677971A combinations of 5-ht2a inverse agonists and antagonists with antipsychotics
03/24/2010CN101677954A Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
03/24/2010CN101676287A 6-(substituted phenoxy)-tetrazolo[5,1-a] phthalazine derivatives as antuepileptics and their pharmaceutically acceptable salts
03/24/2010CN101676286A Azaindoles useful as inhibitors of JAK and other protein kinases
03/24/2010CN101676283A preparation method of naratriptan
03/24/2010CN101676272A preparation method of pramipexole
03/24/2010CN101675992A Beta-amyloid-analogue-t-cell epitop vaccine
03/24/2010CN101675964A externally-applied traditional Chinese medicine composition for treating headache
03/24/2010CN101675938A Preparation method and use of a novel peptide type immunizing agent whole-egg protein peptide
03/24/2010CN101675932A Composition for preventing and treating amyotrophic lateral sclerosis
03/24/2010CN101675928A Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters
03/24/2010CN101675927A therapeutic molecules and methods-1
03/24/2010CN101675926A Analgesics and methods of use
03/24/2010CN100594935C Antibodies that immunospecifically bind to trail receptors
03/24/2010CN100594910C Compound panoxatriol saponin with physiological activity and its preparation and use
03/24/2010CN100594897C Cannabinoid liquid formulations for mucosal amdinistration
03/24/2010CN100594796C Sichuan fritillary bulb mint plum and its producing method
03/23/2010US7683185 6-(4-Dimethylamino-phenylsulfanyl)-hexa-2,4-dienoic acid methyl ester; stimulating hematopoietic cells ex vivo
03/23/2010US7683094 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder
03/23/2010US7683078 Neuronal disorders, autoimmune diseases, cancer, cardiovascular diseases; such as 4-Chloro-N-{5-[1-(4-trifluoromethyl-benzyl)-piperidin-3-ylsulfamoyl]-25 thiophen-2-ylmethyl)-benzamide
03/23/2010US7683075 isoquinoline-3-carboxylic acid{(S)-1-azabicyclo[2.2.2]oct-3-yl}-amide; alpha 7 nicotinic acetylcholine receptor agonists; psychotic disorders such as schizophrenia, mania, depression and anxiety; neurodegenerative disorders such as senile dementia, Alzheimer's disease; attention deficit disorders
03/23/2010US7683074 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents
03/23/2010US7683073 Isoquinoline-1,3,4-trione compounds, the synthetic method and the use thereof
03/23/2010US7683067 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (GSK-3)
03/23/2010US7683062 of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide; dysfunction of peripheral-type benzodiazepine receptors; anticarcinogenic, antiinflammatory agent, neurodegenerative diseases; stresses, arthritis; improved bioavailability, solubility, storage stability
03/23/2010US7683053 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
03/23/2010US7683040 Intranasal formulation of rotigotine
03/23/2010US7682807 Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
03/23/2010US7682635 Aqueous dispersions of nanometric or micrometric particles for encapsulating chemical compounds
03/23/2010US7682632 Tamper-resistant oral opioid agonist formulations
03/23/2010CA2639023A1 Bioscience iii
03/23/2010CA2500485C Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activity
03/23/2010CA2460177C 3-substituted-4-pyrimidone derivatives
03/23/2010CA2418652C Novel 3-substituted urea derivatives and medicinal use thereof
03/23/2010CA2392709C Polyhydroxylated aromatic compounds for the treatment of amyloidosis
03/23/2010CA2377278C Prodrugs of carbamate inhibitors of impdh
03/23/2010CA2352436C Polymorphs of telmisartan, processes for preparing them and their use in the preparation of a pharmaceutical composition
03/23/2010CA2346869C Phospholipid derivatives of non-steroidal anti-inflammatory drugs
03/23/2010CA2332608C Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination
03/23/2010CA2332488C Cells and animals deficient in protein kinase c epsilon
03/23/2010CA2283535C Glycine transporter
03/18/2010WO2010031056A2 Methods and compositions for modulating ire1, src, and abl activity
03/18/2010WO2010031043A2 Reducing or preventing neuroinflammation or neurotoxicity
03/18/2010WO2010030954A1 Spiro-tetracyclic ring compounds as betasecretase modulators and methods of use
03/18/2010WO2010030783A1 Methods for the administration of iloperidone
03/18/2010WO2010030653A2 Nurr1 interacting protein (nuip)
03/18/2010WO2010030607A1 Treatment of pervasive developmental disorders with redox-active therapeutics
03/18/2010WO2010030470A1 Agmatine containing dietary supplements, nutraceuticals, and foods
03/18/2010WO2010030203A1 Monoclonal antibody to human amyloidogenic and modified forms of transthyretin and its use in the detection and treatment of fap and pathologies presenting modified ttr
03/18/2010WO2010029996A1 Pharmaceutical composition
03/18/2010WO2010029995A1 Therapeutic agent for pain
03/18/2010WO2010029958A1 Novel pharmaceutical composition for treatment of nociceptive pain
03/18/2010WO2010029913A1 Mental vigor improver
03/18/2010WO2010029131A1 Use of anti-connexin agents for modulating the therapeutic effect of psychotropic drugs
03/18/2010WO2010028776A1 Piperazine derivatives for binding and imaging amyloid plaques and their use
03/18/2010WO2010028769A1 1-amino-alkylcyclohexane derivatives for the treatment of cognitive impairment in tinnitus
03/18/2010WO2010028676A1 Use of a peptide as a therapeutic agent
03/18/2010WO2010028675A1 Use of tyrosinase ( 192-200 ) nonapeptide as a therapeutic agent
03/18/2010WO2010028674A1 Use of a peptide as a therapeutic agent
1 ... 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 ... 1833